BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/25/2021 8:37:41 AM | Browse: 794 | Download: 1465
 |
Received |
|
2021-02-13 08:47 |
|
Peer-Review Started |
|
2021-02-13 08:50 |
|
First Decision by Editorial Office Director |
|
2021-04-06 01:07 |
|
Return for Revision |
|
2021-04-06 01:07 |
|
Revised |
|
2021-04-12 11:07 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-06-22 14:08 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-06-22 14:30 |
|
Articles in Press |
|
2021-06-22 14:30 |
|
Edit the Manuscript by Language Editor |
|
2021-11-23 08:30 |
|
Typeset the Manuscript |
|
2021-12-06 06:51 |
|
Publish the Manuscript Online |
|
2021-12-25 08:37 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Biology |
| Manuscript Type |
Opinion Review |
| Article Title |
Stem cell-derived biofactors fight against coronavirus infection
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mohammadreza Ardalan, Leila Chodari, Sepideh Zununi Vahed, Seyed Mahdi Hosseiniyan Khatibi, Aziz Eftekhari, Soodabeh Davaran, Magali Cucchiarini, Leila Roshangar and Elham Ahmadian |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Elham Ahmadian, PhD, Assistant Professor, Kidney Research Center, Tabriz University of Medical Sciences, Golgasht Avenue, Tabriz 5166614766, Iran. ahmadian.l.h.m@gamil.com |
| Key Words |
COVID-19; Secretome; Mesenchymal stem cell; Exosome; Stem cell; Biofactors |
| Core Tip |
The world has witnessed unbelievable damage from the coronavirus disease 2019 (COVID-19) pandemic. The rapid propagation of the disease requires emerging therapeutical strategies. The central role of the immune system during the infection highlights the importance of a balanced immune response in order to prohibit overexaggerated responses and further multiorgan dysfunctions. Stem cell and stem cell-derived secretome-related therapies have gained increasing momentum in the treatment of a broad range of diseases in the past decade. In particular, the immunomodulatory properties of stem cell-derived biofactors could be a new avenue in the treatment of COVID-19 patients. |
| Publish Date |
2021-12-25 08:37 |
| Citation |
Ardalan M, Chodari L, Zununi Vahed S, Hosseiniyan Khatibi SM, Eftekhari A, Davaran S, Cucchiarini M, Roshangar L, Ahmadian E. Stem cell-derived biofactors fight against coronavirus infection. World J Stem Cells 2021; 13(12): 1813-1825 |
| URL |
https://www.wjgnet.com/1948-0210/full/v13/i12/1813.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v13.i12.1813 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
